Live Quote · NASDAQEXELHealthcare· Biotechnology

Exelixis, Inc.

$64.63▼ 1.82%($-1.20)
MKT CAP $16.25BNEXT EARNINGS Feb 9, 2027
50%
Bullish
TickerSpark Score
87/100
▌ Strong
73
Valuation
100
Profitability
80
Growth
80
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXEL research report →

Analyst Price Target
$54.20-16.1% vs. today

Range $49 – $65

Analyst RatingHold
15 Buy18 Hold0 Sell

Price Chart

+54.69% · this period
$72.75$56.75$40.74Nov 20May 26Nov 20
52-Week Range73% of range
Low
$39.71
Current
$64.63
High
$73.69